Global Mobile Gamma Cameras Market - 2023-2030

Global Mobile Gamma Cameras Market - 2023-2030

Global Mobile Gamma Cameras Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.

A mobile gamma camera system is an imaging technique to generate functional scans of small and large organs including brain, cardiac, neurological, breast, thyroid, pancreas and kidney applications. The mobile gamma camera scans the body by using a procedure that follows injecting a radionucleotide in the body or organ and then recording the resulting radioactivity by image scanning.

The Mobile Gamma Camera is a fully mobile unit. It can be positioned and used at the hospital bed without moving the patient. With an acquisition time of just 2 minutes and a total examination time from the injection of radioisotopes to the final images of just 10 minutes, the 3D Mobile Gamma Camera is a powerful bedside decision-making tool useful even in the emergency room.

Market Dynamics: Drivers and Restraints

Rise in technological advancements

The rise in technological advancements is one of the significant key driver that helps the market to grow during the forecast period. The development of advanced gamma camera systems with improved imaging capabilities is driving the adoption of mobile gamma cameras.

For instance, in June 2023, Serac Imaging launched clinical testing of a portable gamma camera in the US. It is a portable high-resolution hybrid gamma optical camera developed by UK-based company Serac Imaging Systems and is now in clinical testing in the United States. In technology that was originally developed by the University of Leicester for satellites in X-ray astronomy, the device uses radiation to image radioisotopes, which are administered to the patient. This reveals information about the function of the body, for example, if there are blockages.

Some potential applications of the camera include bone, renal and infection imaging, lymphatic imaging, and sentinel lymph node localisation, as well as small organ imaging such as the thyroid.

Hence, the new pharmaceuticals open up new horizons, and we may be able to treat, even cure new diseases. With new cameras and better, quicker detectors, images are sharper, acquisitions are faster, and the radiation burden on patients is reduced. AI may prove to be an important aid to physicians. Furthermore, the global mobile gamma cameras market is also driven by various other factors like, a rise in the prevalence of chronic diseases, increasing adoption of mobile gamma cameras and others will further help the market during the forecast period.

Market Dynamics: Restraint

The introduction of new medical devices like mobile gamma cameras faces regulatory and reimbursement challenges, impacting their adoption and affordability. Also, cost constraints, such as high initial investment and ongoing maintenance, can hamper market accessibility, especially in resource-limited settings, affecting the adoption of these devices.

Segment Analysis

The global mobile gamma cameras market is segmented based on product type, indication, end user and region.

The triple mobile gamma cameras segment from the product type segment accounted for approximately 43.5% of the mobile gamma cameras market share

The triple mobile gamma cameras segment from the product type segment accounted for approximately 43.5% and is expected to be dominated during the forecast period. Among the type segment triple-head mobile gamma cameras are witnessing the fastest growth in the market due to the superior quality of the obtained images, high speed of the resolution of imagining, and cost-effectiveness. These cameras are majorly used for the brain and cardiac SPECT and among healthcare providers and patients the demand for these mobile gamma cameras is high owing to several benefits offered by them.

Also, Triple-head mobile gamma cameras provide higher imaging capabilities by concurrently using three detectors, resulting in improved picture quality, quicker imaging times, and increased patient productivity.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the high prevalence of chronic diseases, such as cancer and heart disease. The demand for diagnostic tools like mobile gamma cameras to detect and monitor these conditions continues to grow, as the population ages. Also, novel product launches, and ongoing advancements in mobile gamma camera technology, including improved image quality and reduced radiation exposure, are driving adoption in the country.

For instance, in May 2020, Digirad stated the launch of updated versions of its Ergo general-purpose nuclear camera and Cardius line of SPECT cameras. The upgraded cameras were developed throughout 2019 and are making their clinical debut this quarter in markets throughout the United States and Canada.

COVID-19 Impact Analysis

The novel coronavirus pandemic has resulted in a significant decline in the treatment of renal diseases worldwide. During the peak of the pandemic, there was a steep reduction in the number of patients with kidney failure accessing treatment such as transplants and dialysis. Such factors may have asserted a negative influence on the steady growth of the mobile gamma cameras industry over the past months.

Market Segmentation

By Product Type
• Triple Mobile Gamma Cameras
• Double Mobile Gamma Cameras
• Single Head Mobile Gamma Cameras
• Hand Held Mobile Gamma Cameras

By Indication
• Cardiac Imaging
• Breast Imaging
• Hepatobiliary Imaging
• GI Imaging
• Renal Imaging
• Brain Imaging
• Others

By End User
• Hospitals
• Ambulatory Surgical Centers
• Cancer Research Institutes
• Specialized Clinics

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Digirad Corporation, DDD-Diagnostic A/S, Spectrum Dynamics Medical, MIE America, LabLogic Systems Ltd, Crystal Photonics, Oncovision Inc, GAEDE Medizinsysteme GmbH, Mediso Ltd, GE Healthcare and among others.

Key Developments

 In May 2022, GE Healthcare announced the launch of its new mobile gamma camera, the Discovery NM/CT 570c. The Discovery NM/CT 570c is a hybrid mobile gamma camera that combines SPECT/CT imaging capabilities in a single device.

Why Purchase the Report?
• To visualize the global mobile gamma cameras market segmentation based on product type, indication, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of mobile gamma cameras market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global mobile gamma cameras market report would provide approximately 77 tables, 79 figures and 187 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies